Showing results (51-60 of 82) with videos related to
Sort By:
Pageof 9
Journal of Thrombosis and Thrombolysis|September 29, 2001
Short-term comparative outcomes associated with the use of GP IIb/IIIa antagonists in patients undergoing coronary interventionC Kimmelstiel, R Phang, A Rehman, et al.Circulation|June 19, 2012
Suppression of arterial thrombosis without affecting hemostatic parameters with a cell-penetrating PAR1 pepducinPing Zhang, András Gruber, Shogo Kasuda, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 22, 2019
First-in-human experience with occlusion of the superior vena cava to reduce cardiac filling pressures in congestive heart failureNavin K Kapur, Richard H Karas, Sarah Newman, et al.Thrombosis Research|March 10, 2019
Enhanced potency of prasugrel on protease-activated receptors following bivalirudin treatment for PCI as compared to clopidogrelCarey Kimmelstiel, Ryan Stevenson, Nga Nguyen, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|October 8, 2020
PAR1 (Protease-Activated Receptor 1) Pepducin Therapy Targeting Myocardial Necrosis in Coronary Artery Disease and Acute Coronary Syndrome Patients Undergoing Cardiac Catheterization: A Randomized, Placebo-Controlled, Phase 2 StudyAthan Kuliopulos, Paul A Gurbel, Jeffrey J Rade, et al.The Journal of Invasive Cardiology|February 4, 2014
Quantitative assessment of myocardial perfusion using time-density curve analysis after elective percutaneous coronary interventionMichele Esposito, Nimish N Shah, Ravikiran Korabathina, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 1, 2020
Incidence and clinical outcomes of stroke in ST-elevation myocardial infarction and cardiogenic shockMohit Pahuja, Omar Chehab, Sagar Ranka, et al.The American Journal of Cardiology|March 11, 2005
Impact of obesity on revascularization and restenosis rates after bare-metal and drug-eluting stent implantation (from the TAXUS-IV trial)Eugenia Nikolsky, Edward Kosinski, Gregory J Mishkel, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|March 25, 2021
Deficiency of MMP1a (Matrix Metalloprotease 1a) Collagenase Suppresses Development of Atherosclerosis in Mice: Translational Implications for Human Coronary Artery DiseaseElizabeth K Fletcher, Yanling Wang, Laura K Flynn, et al.Clinical Pharmacokinetics|January 21, 2022
Pharmacokinetic and Pharmacodynamic Profile of a Novel Phospholipid Aspirin FormulationDominick J Angiolillo, Jayne Prats, Efthymios N Deliargyris, et al.Pageof 9